Form D · Other
Hearsay Labs, Inc.
San Francisco, CA · CIK 0001527553
Offering snapshot reported Aug 10, 2011 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2011 | Initial | $17,999,999 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-164209
Series B Preferred Stock; Common Stock issuable upon conversion thereof
Source: Form D, filed Aug 10, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Garrity | Director, Executive |
| Joe Lambert | Executive |
| Thomas Layton | Director |
| Jon Sakoda | Director |
| Bryan Schreier | Director |
| Clara Shih | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
301 Brannan Street, 4 Th Floor
San Francisco, CA, 94107
San Francisco, CA, 94107